GAZYVA (obinutuzumab) for Chronic Lymphocytic Leukemia - Cancer Therapy Advisor

GAZYVA (obinutuzumab) for Chronic Lymphocytic Leukemia

Slideshow

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

This slideshow reviews drug information for GAZYVA (obinutuzumab) for chronic lymphocytic leukemia.

Table of Contents

Slide 3: Indication, Dosage, and Administration
Slide 10: Use in Specific Populations
Slide 12: Clinical Pharmacology
Slide 16: Warnings and Precautions
Slide 20: Clinical Safety and Efficacy
Slide 26: Drug Storage and Supply
Slide 28: References

Next hm-slideshow in Slides